The new pharmaceutical pricing reforms leave many controls in place, sparking questions on the objective of the changes. Here we push past the fog to see what's really going on
The latest Drug Administration Law amendments introduce welcome changes such as relaxed permit requirements and free prices. Pharmaceutical companies should keep abreast of the drug pricing reform, and track review and approval changes in the pipeline
The latest Drug Administration Law amendments introduce welcome changes such as relaxed permit requirements and free prices. Pharmaceutical companies should keep abreast of the drug pricing reform, and track review and approval changes in the pipeline
China's efforts to crack down on misleading, fraudulent claims forces an industry rethink as they overturn the effects of years of aggressive marketing. The new law regulates content, target audiences and specific industries like tobacco and healthcare, and will increase compliance costs for consumer-oriented businesses
Under the SAIC's new rules, business operators are now responsible for compensating consumers for faulty products sold by third party sellers. Operators should have strict measures in place to avoid losses through these reimbursement claims